$AVXL Dr. Missling, just a heads-up for the Tuesday conference, investors will be comfortable holding the shares.

$AVXL At this level, the remaining float could easily get locked up by institutional investors and they will likely come in the next days/weeks for this very high reward / low risk company.

$AVXL YES A good day for the serious investors here.

$AVXL Happy New 2023 year, year of incredible gains/returns to AVXL investors and year when finally we will have approved treatment against CNS diseases 😀 (i’m not talking about biib drug).

$AVXL to any BIG investors out there, this is a great place (AVXL) to drop 50m on shares.

$AVXL all real investors can feel very comfortable. ..

reignite some investor confidence.

The interactions with their lead investigator, Dr. MacFarlane, and the BIg pharma executive are incredible since most investors would never be able to access the thoughts of people in those positions regarding their biotech investment(s) Amazing stuff.

$AVXL This is definitely going to get the attention of a big investor.

As investors digest the revenue potential, either via approval for RETT, or partnership for AD and PD, the stock price will rise accordingly.

Catalysts on Monday, and investors are showing they believe in MYO. TRENDING

Just trying to help out fellow investors that since are part of Cassava obviously appreciate a great opportunity 🙂

Trust that there's a strategy at work to unlock the door to great opportunity for the AD community and us as investors.

Patient investors will be rewarded.. New data incoming anyday..

remi wont let down shch a big investor.

This is going to be a life/game changer for victims of the disease and stuff spined investors.

Because it’s loaded with emotional investors that really think it’s a worthwhile gamble.

$SAVA somebody called me A rookie investor I’m so flattered thank you

It helps put a floor on the price and shows confidence from big investors.

Suspect there will be many more to join us as investors as further data solidifies the case that this is a very unique investing opportunity.

As the company continues to bring new treatments to market, it is likely that Biocryst will continue to be a leader in the field of rare disease treatment, providing both patients and investors alike with a brighter future.

For long-term investors, Pfizer could be a good stock to load up on right now.

$BCRX European stocks rose on Friday as investors took an optimistic view of a week of data releases that showed economies in Europe and the US were more robust than expected.

Got their investors to believe in the company and Praised the CEO, all while lining up sales into the endless pumping of riches coming our way!

I know this board has always been a great group of investors.

An exciting time to be an investor!

Investors win.

$BCRX European stocks were on track for a sixth successive week of gains on Friday and government bond yields globally traded near multi-week lows as investors reacted to positive data and signs central banks may not hike rates as aggressively as feared.

$BCRX November investor deck is great